98 filings
Page 4 of 5
8-K
sdjivipf6k
16 Aug 19
Beyond Airâ„¢ Reports Financial Results for Fiscal First Quarter 2020
12:00am
8-K
tux5o
15 Jul 19
Beyond AirTM Announces New NASDAQ Ticker Symbol is XAIR
4:06pm
8-K
g0jdo67susfdko ha4d7
28 Jun 19
CORRECTING and REPLACING - AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results
4:15pm
8-K
z1dhlr
7 Jun 19
AIT Therapeutics Announces $8 Million PIPE Financing
4:30pm
8-K
qn8bzg6
3 May 19
AIT Therapeutics Announces Uplisting to the Nasdaq Capital Market
8:35am
8-K
25a 440yi646h7xbhcm
17 Apr 19
Changes in Registrant's Certifying Accountant
4:30pm
8-K
ggs sr3mmr2r
26 Feb 19
Other Events
8:45am
8-K
bcq38dgsc3xm
14 Feb 19
AIT Therapeutics Reports Financial Results for Fiscal Third Quarter 2019
12:00am
8-K
4im2bgn1 97yzm0o
29 Jan 19
Entry into a Material Definitive Agreement
4:05pm
8-K
0cxmqvevz2d305hrw0kb
3 Jan 19
AIT to receive up to $32.5 million in up-front and regulatory milestones
12:00am
8-K
l9oo1jhb f40klo0
13 Nov 18
Changes in Registrant's Certifying Accountant
4:05pm
8-K
hfypwnm7ic
1 Nov 18
AIT Therapeutics Appoints Douglas J. Beck as Chief Financial Officer
5:00pm
8-K
kub756vu dxk
17 Aug 18
AIT Therapeutics Reports Financial Results for First Fiscal Quarter 2019
12:50pm
8-K
pn7r fiv5o
13 Aug 18
AIT Therapeutics Announces $20 Million Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
4:00pm
8-K
w6qu4n g3
19 Jun 18
Announced positive top-line data for Nitric Oxide in Bronchiolitis (NO-BRO) Pilot Study
12:00am
8-K
i38mg4o0wogt kw07odh
10 May 18
Amendments to Articles of Incorporation or Bylaws
4:17pm
8-K
uy57wt4v
7 May 18
Other Events
2:45pm
8-K
vueyn
20 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
vb2 n0venn9jfev
22 Mar 18
AIT Therapeutics Reports Year End 2017 Financial Results
12:00am
8-K
3pixx5f9x oa
22 Feb 18
Entry into a Material Definitive Agreement
12:00am